Drug Information

Drug General Information
Drug ID
D03SKC
Former ID
DNCL002876
Drug Name
KRP-104
Synonyms
Antigen inhibitor
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 2 [522106]
Company
ActivX Biosciences
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Modulator [550202]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 522106ClinicalTrials.gov (NCT00525330) A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone. U.S. National Institutes of Health.
Ref 550202Clinical pipeline report, company report or official report of Activx.